Pancreatic Cancer Research

ResearcherPhilipps University of MarburgActive in the last 2 years

Malte Buchholz

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-2833-995X; OpenAlex author ID A5045880069. Sources: OpenAlex.

Their work

Papers
29 (first author 0, last author 5)
Trials
0
Grants
0
Labs led
1
Collaborators
93
Papers, trials and grants by year

2011: 2 papers · 2012: 2 papers · 2013: 4 papers · 2014: 1 paper · 2015: 2 papers · 2016: 2 papers · 2017: 1 paper · 2018: none · 2019: 1 paper · 2020: 1 paper · 2021: 2 papers · 2022: none · 2023: 5 papers · 2024: 3 papers · 2025: 2 papers · 2026: 1 paper

Papers 29

  1. A Comprehensive Assessment of the Causal Relationship between Atopic Conditions and Pancreatic Cancer Risk: A Two-Sample Mendelian Randomization Study. Co-author DOI 10.1158/1055-9965.epi-25-1601↗
  2. Combined analysis of a serum mRNA/miRNA marker signature and CA 19-9 for timely and accurate diagnosis of recurrence after resection of pancreatic ductal adeno… Co-author DOI 10.1002/ueg2.12676↗
  3. The long non-coding RNA NEAT1 contributes to aberrant STAT3 signaling in pancreatic cancer and is regulated by a metalloprotease-disintegrin ADAM8/miR-181a-5p … Co-author DOI 10.1007/s13402-024-01001-0↗
  4. BAG6 restricts pancreatic cancer progression by suppressing the release of IL33-presenting extracellular vesicles and the activation of mast cells. Co-author DOI 10.1038/s41423-024-01195-1↗
  5. SAMD1 suppresses epithelial-mesenchymal transition pathways in pancreatic ductal adenocarcinoma. Co-author DOI 10.1371/journal.pbio.3002739↗
  6. Optimized Spheroid Model of Pancreatic Cancer Demonstrates Influence of Macrophage-T Cell Interaction for Intratumoral T Cell Motility. Co-author DOI 10.3390/cancers17010051↗
  7. Dissecting the role of toll-like receptor 7 in pancreatic cancer. Last author DOI 10.1002/cam4.5606↗
  8. IL-17A-producing CD8+ T cells promote PDAC via induction of inflammatory cancer-associated fibroblasts. Co-author DOI 10.1136/gutjnl-2022-327855↗
  9. IL18 Receptor Signaling Regulates Tumor-Reactive CD8+ T-cell Exhaustion via Activation of the IL2/STAT5/mTOR Pathway in a Pancreatic Cancer Model. Co-author DOI 10.1158/2326-6066.cir-22-0398↗
  10. Corrigendum: Clinical impact of molecular subtyping of pancreatic cancer. Co-author DOI 10.3389/fcell.2023.1179559↗
  11. IL18 Receptor Signaling Inhibits Intratumoral CD8+ T-Cell Migration in a Murine Pancreatic Cancer Model. Co-author DOI 10.3390/cells12030456↗
  12. Clinical Impact of Molecular Subtyping of Pancreatic Cancer. Co-author DOI 10.3389/fcell.2021.743908↗
  13. Unraveling the Molecular Tumor-Promoting Regulation of Cofilin-1 in Pancreatic Cancer. Co-author DOI 10.3390/cancers13040725↗
  14. The Immune Microenvironment in Pancreatic Cancer. Co-author DOI 10.3390/ijms21197307↗
  15. Stromal biology and therapy in pancreatic cancer: ready for clinical translation? Co-author DOI 10.1136/gutjnl-2018-316451↗
  16. The deubiquitinating enzyme USP5 promotes pancreatic cancer via modulating cell cycle regulators. Last author DOI 10.18632/oncotarget.19882↗
  17. PLAC8 Localizes to the Inner Plasma Membrane of Pancreatic Cancer Cells and Regulates Cell Growth and Disease Progression through Critical Cell-Cycle Regulator… Last author DOI 10.1158/0008-5472.can-15-0216↗
  18. Role of BCL9L in transforming growth factor-β (TGF-β)-induced epithelial-to-mesenchymal-transition (EMT) and metastasis of pancreatic cancer. Co-author DOI 10.18632/oncotarget.12455↗
  19. Kif20a inhibition reduces migration and invasion of pancreatic cancer cells. Co-author DOI 10.1016/j.jss.2015.03.070↗
  20. A multistep high-content screening approach to identify novel functionally relevant target genes in pancreatic cancer. Co-author DOI 10.1371/journal.pone.0122946↗
  21. Key role of dual specificity kinase TTK in proliferation and survival of pancreatic cancer cells. Last author DOI 10.1038/bjc.2014.460↗
  22. Aspirin prolongs survival and reduces the number of Foxp3+ regulatory T cells in a genetically engineered mouse model of pancreatic cancer. Co-author DOI 10.1007/s00423-013-1105-2↗
  23. Claudin-4-targeted optical imaging detects pancreatic cancer and its precursor lesions. Co-author DOI 10.1136/gutjnl-2012-302577↗
  24. WNT5A-NFAT signaling mediates resistance to apoptosis in pancreatic cancer. Co-author DOI 10.1593/neo.121312↗
  25. Synthetic lethality screen identifies RPS6KA2 as modifier of epidermal growth factor receptor activity in pancreatic cancer. Co-author DOI 10.1593/neo.131660↗
  26. Lack of CCR7 expression is rate limiting for lymphatic spread of pancreatic ductal adenocarcinoma. Co-author DOI 10.1002/ijc.26502↗
  27. Immunoassay-based proteome profiling of 24 pancreatic cancer cell lines. Co-author DOI 10.1016/j.jprot.2012.04.042↗
  28. Stromal biology and therapy in pancreatic cancer. Co-author DOI 10.1136/gut.2010.226092↗
  29. Comprehensive analysis of cellular galectin-3 reveals no consistent oncogenic function in pancreatic cancer cells. Last author DOI 10.1371/journal.pone.0020859↗

Closest collaborators

The 25 strongest of 93 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Thomas Mathias Gress · 22 shared papers, 2011–2025 · strength 2.09
  2. Magdalena Huber · 6 shared papers, 2020–2024 · strength 0.97
  3. Christian Alexander Bauer · 6 shared papers, 2019–2024 · strength 0.89
  4. Matthias Lauth · 5 shared papers, 2019–2025 · strength 0.68
  5. Thilo Hackert · 4 shared papers, 2017–2025 · strength 0.54
  6. Detlef Klaus Bartsch · 4 shared papers, 2013–2025 · strength 0.52
  7. Veronika Lutz · 3 shared papers, 2023–2024 · strength 0.49
  8. Markus Wolfgang Büchler · 3 shared papers, 2021–2025 · strength 0.48
  9. Corinna Ulrike Keber · 3 shared papers, 2023–2024 · strength 0.45
  10. Elena Nasiri · 2 shared papers, 2023–2024 · strength 0.41
  11. Aldo Scarpa · 3 shared papers, 2014–2025 · strength 0.41
  12. Hans Armin Kestler · 3 shared papers, 2016–2025 · strength 0.38
  13. Rita Teresa Lawlor · 2 shared papers, 2023–2025 · strength 0.37
  14. Bence Sipos · 6 shared papers, 2012–2021 · strength 0.34
  15. Jörg Walter Bartsch · 2 shared papers, 2020–2025 · strength 0.31
  16. Robert Liefke · 2 shared papers, 2023–2024 · strength 0.30
  17. Nathalia A. Giese · 3 shared papers, 2012–2025 · strength 0.28
  18. Anna I. Brichkina · 2 shared papers, 2023–2024 · strength 0.27
  19. Felix S.R. Picard · 2 shared papers, 2023 · strength 0.27
  20. Emily P. Slater · 2 shared papers, 2020–2023 · strength 0.27
  21. Kongyuan Wei · 2 shared papers, 2021–2023 · strength 0.26
  22. Peter J. Bailey · 2 shared papers, 2021–2023 · strength 0.26
  23. Jingyu An · 2 shared papers, 2021–2023 · strength 0.26
  24. Susanne Roth · 2 shared papers, 2021–2023 · strength 0.26
  25. Christoph Springfeld · 2 shared papers, 2021–2023 · strength 0.26

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.